130 related articles for article (PubMed ID: 31235261)
1. Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors.
Follows B; Fessler S; Baumeister T; Campbell AM; Zablocki MM; Li H; Gotur D; Wang Z; Zheng X; Molz L; Nguyen C; Herbertz T; Wang L; Bair K
Bioorg Med Chem Lett; 2019 Aug; 29(16):2375-2382. PubMed ID: 31235261
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods.
Pelz NF; Bian Z; Zhao B; Shaw S; Tarr JC; Belmar J; Gregg C; Camper DV; Goodwin CM; Arnold AL; Sensintaffar JL; Friberg A; Rossanese OW; Lee T; Olejniczak ET; Fesik SW
J Med Chem; 2016 Mar; 59(5):2054-66. PubMed ID: 26878343
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
Petros AM; Swann SL; Song D; Swinger K; Park C; Zhang H; Wendt MD; Kunzer AR; Souers AJ; Sun C
Bioorg Med Chem Lett; 2014 Mar; 24(6):1484-8. PubMed ID: 24582986
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
Tanaka Y; Aikawa K; Nishida G; Homma M; Sogabe S; Igaki S; Hayano Y; Sameshima T; Miyahisa I; Kawamoto T; Tawada M; Imai Y; Inazuka M; Cho N; Imaeda Y; Ishikawa T
J Med Chem; 2013 Dec; 56(23):9635-45. PubMed ID: 24215352
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.
Lanning ME; Yu W; Yap JL; Chauhan J; Chen L; Whiting E; Pidugu LS; Atkinson T; Bailey H; Li W; Roth BM; Hynicka L; Chesko K; Toth EA; Shapiro P; MacKerell AD; Wilder PT; Fletcher S
Eur J Med Chem; 2016 May; 113():273-92. PubMed ID: 26985630
[TBL] [Abstract][Full Text] [Related]
6. Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology.
Li K
Bioorg Med Chem Lett; 2021 Jan; 32():127717. PubMed ID: 33253879
[TBL] [Abstract][Full Text] [Related]
7. MCL-1 inhibitors - where are we now (2019)?
Fletcher S
Expert Opin Ther Pat; 2019 Nov; 29(11):909-919. PubMed ID: 31566022
[No Abstract] [Full Text] [Related]
8. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
9. Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.
Drennen B; Scheenstra JA; Yap JL; Chen L; Lanning ME; Roth BM; Wilder PT; Fletcher S
ChemMedChem; 2016 Apr; 11(8):827-33. PubMed ID: 26844930
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors.
Wan Y; Li Y; Yan C; Wen J; Tang Z
Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192
[TBL] [Abstract][Full Text] [Related]
11. The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia.
Besbes S; Pocard M; Mirshahi M; Billard C
Crit Rev Oncol Hematol; 2016 Apr; 100():32-6. PubMed ID: 26899021
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Mcl-1 inhibitors based on a thiazolidine-2,4-dione scaffold.
Whiting E; Raje MR; Chauhan J; Wilder PT; Van Eker D; Hughes SJ; Bowen NG; Vickers GEA; Fenimore IC; Fletcher S
Bioorg Med Chem Lett; 2018 Feb; 28(3):523-528. PubMed ID: 29329659
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
Li R; Cheng C; Balasis ME; Liu Y; Garner TP; Daniel KG; Li J; Qin Y; Gavathiotis E; Sebti SM
Eur J Med Chem; 2015 Jan; 90():315-331. PubMed ID: 25437618
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Optimization of 3-Phenyl-
Li Y; Fan W; Gong Q; Tian J; Zhou M; Li Q; Uwituze LB; Zhang Z; Hong R; Wang R
J Med Chem; 2021 Jul; 64(14):10260-10285. PubMed ID: 34228434
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein.
Abid M; Sonawane YA; Contreras JI; Rana S; Natarajan A
Curr Med Chem; 2017; 24(40):4488-4514. PubMed ID: 28901269
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.
Szlávik Z; Ondi L; Csékei M; Paczal A; Szabó ZB; Radics G; Murray J; Davidson J; Chen I; Davis B; Hubbard RE; Pedder C; Dokurno P; Surgenor A; Smith J; Robertson A; LeToumelin-Braizat G; Cauquil N; Zarka M; Demarles D; Perron-Sierra F; Claperon A; Colland F; Geneste O; Kotschy A
J Med Chem; 2019 Aug; 62(15):6913-6924. PubMed ID: 31339316
[TBL] [Abstract][Full Text] [Related]
18. Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design.
Burke JP; Bian Z; Shaw S; Zhao B; Goodwin CM; Belmar J; Browning CF; Vigil D; Friberg A; Camper DV; Rossanese OW; Lee T; Olejniczak ET; Fesik SW
J Med Chem; 2015 May; 58(9):3794-805. PubMed ID: 25844895
[TBL] [Abstract][Full Text] [Related]
19. Small molecule Mcl-1 inhibitors for the treatment of cancer.
Belmar J; Fesik SW
Pharmacol Ther; 2015 Jan; 145():76-84. PubMed ID: 25172548
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1.
Beekman AM; Howell LA
ChemMedChem; 2016 Apr; 11(8):802-13. PubMed ID: 26696548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
